Success Metrics

Clinical Success Rate
76.9%

Based on 10 completed trials

Completion Rate
77%(10/13)
Active Trials
3(17%)
Results Posted
50%(5 trials)
Terminated
3(17%)

Phase Distribution

Ph phase_2
3
17%
Ph not_applicable
3
17%
Ph phase_1
5
28%
Ph phase_3
4
22%
Ph phase_4
3
17%

Phase Distribution

5

Early Stage

3

Mid Stage

7

Late Stage

Phase Distribution18 total trials
Phase 1Safety & dosage
5(27.8%)
Phase 2Efficacy & side effects
3(16.7%)
Phase 3Large-scale testing
4(22.2%)
Phase 4Post-market surveillance
3(16.7%)
N/ANon-phased studies
3(16.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

76.9%

10 of 13 finished

Non-Completion Rate

23.1%

3 ended early

Currently Active

3

trials recruiting

Total Trials

18

all time

Status Distribution
Active(5)
Completed(10)
Terminated(3)

Detailed Status

Completed10
Terminated3
Active, not recruiting2
Recruiting1
Not yet recruiting1
Enrolling by invitation1

Development Timeline

Analytics

Development Status

Total Trials
18
Active
3
Success Rate
76.9%
Most Advanced
Phase 4

Trials by Phase

Phase 15 (27.8%)
Phase 23 (16.7%)
Phase 34 (22.2%)
Phase 43 (16.7%)
N/A3 (16.7%)

Trials by Status

recruiting16%
not_yet_recruiting16%
completed1056%
terminated317%
active_not_recruiting211%
enrolling_by_invitation16%

Recent Activity

3 active trials
Showing 5 of 18
active_not_recruitingphase_2

Screening and Multiple Intervention on Lung Epidemics

NCT03654105
not_yet_recruitingnot_applicable

Smoking Harm Reduction Using E-cigarettes and Cytisine

NCT07274475
enrolling_by_invitationnot_applicable

Cytisine vs Nicotine Replacement Therapy

NCT03249428
recruitingphase_4

Combination Nicotine Replacement Therapy, Cytisine, or Varenicline for Smoking Cessation

NCT06832085
completedphase_4

Cytisine for Smoking Cessation

NCT05729243
View all 18 trials

Clinical Trials (18)

Showing 18 of 18 trials
NCT03654105Phase 2

Screening and Multiple Intervention on Lung Epidemics

Active Not Recruiting
NCT07274475Not Applicable

Smoking Harm Reduction Using E-cigarettes and Cytisine

Not Yet Recruiting
NCT03249428Not Applicable

Cytisine vs Nicotine Replacement Therapy

Enrolling By Invitation
NCT06832085Phase 4

Combination Nicotine Replacement Therapy, Cytisine, or Varenicline for Smoking Cessation

Recruiting
NCT05729243Phase 4

Cytisine for Smoking Cessation

Completed
NCT05311085Phase 3

Cytisine and E-cigarettes With Supportive Text-messaging for Smoking Cessation (Cess@Tion)

Completed
NCT05102123Phase 3

PeRiopEratiVE SmokiNg CessaTion Trial

Active Not Recruiting
NCT04126135Phase 4

Comparative Effectiveness of Cystine Versus Nicotine Replacement Therapy

Completed
NCT04286295Not Applicable

Cytisine Compared to Combination NRT in Relapsed Smokers

Terminated
NCT04015414Phase 3

Varenicline Versus Cytisine for Smoking Cessation in Primary Care Setting

Completed
NCT02957786Phase 3

Cytisine Versus Varenicline for Smoking Cessation

Completed
NCT02797587Phase 2

Studying Partial-agonists for Ethanol and Tobacco Elimination in Russians With HIV (St PETER HIV)

Completed
NCT03848208Phase 1

A Single Dose-escalation Study of Cytisine in Adult Smokers

Completed
NCT03709823Phase 2

Trial of Cytisine in Adult Smokers

Completed
NCT03303911Phase 1

A Pharmacokinetic and Pharmacodynamic Evaluation of Cytisine in Healthy Smokers

Terminated
NCT03509948Phase 1

A Study in Healthy Smokers to Investigate the Effect of Food on the Bioavailability of Cytisine in a New Formulation

Completed
NCT02585024Phase 1

Cytisine Pharmacokinetics and Dose Response (C-DRAKS 3 and C-DRAKS 4)

Terminated
NCT03268343Phase 1

A Study in Healthy Volunteers to Investigate the Effect of Food on the Bioavailability of Cytisine

Completed

All 18 trials loaded

Drug Details

Intervention Type
DIETARY SUPPLEMENT
Total Trials
18